Detalhe da pesquisa
1.
Transforming vaccine development.
Semin Immunol
; 50: 101413, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33127296
2.
Who to vaccinate first? A peek at decision-making in a pandemic.
Nature
; 607(7918): 235-238, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35821419
3.
A Systematic Framework for Prioritizing Burden of Disease Data Required for Vaccine Development and Implementation: The Case for Group A Streptococcal Diseases.
Clin Infect Dis
; 75(7): 1245-1254, 2022 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35438130
4.
Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed.
PLoS Med
; 18(9): e1003772, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516558
5.
Antibody-Dependent, Gamma Interferon-Independent Sterilizing Immunity Induced by a Subunit Malaria Vaccine.
Infect Immun
; 87(10)2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31308085
6.
The Path to Group A Streptococcus Vaccines: World Health Organization Research and Development Technology Roadmap and Preferred Product Characteristics.
Clin Infect Dis
; 69(5): 877-883, 2019 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30624673
7.
Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children.
N Engl J Med
; 374(26): 2519-29, 2016 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27355532
8.
Vaccine candidates for poor nations are going to waste.
Nature
; 564(7736): 337-339, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30560957
9.
malERA: An updated research agenda for malaria elimination and eradication.
PLoS Med
; 14(11): e1002456, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29190300
10.
Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countries.
Malar J
; 16(1): 433, 2017 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29078773
11.
Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study.
J Infect Dis
; 214(5): 762-71, 2016 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27296848
12.
Clostridium difficile and methicillin-resistant Staphylococcus aureus: emerging concepts in vaccine development.
Annu Rev Med
; 62: 201-15, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-20707676
13.
Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries.
Lancet Glob Health
; 11(11): e1819-e1826, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37858591
14.
Efforts to Develop Pfs25 Vaccines.
Am J Trop Med Hyg
; 2022 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35895392
15.
Accelerating access for all through research and innovation in immunization: Recommendations from Strategic Priority 7 of the Immunization Agenda 2030.
Vaccine
; 2022 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36529593
16.
Standardization of Epidemiological Surveillance of Invasive Group A Streptococcal Infections.
Open Forum Infect Dis
; 9(Suppl 1): S31-S40, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36128405
17.
Standardization of Epidemiological Surveillance of Group A Streptococcal Cellulitis.
Open Forum Infect Dis
; 9(Suppl 1): S25-S30, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36128406
18.
Standardization of Epidemiological Surveillance of Acute Poststreptococcal Glomerulonephritis.
Open Forum Infect Dis
; 9(Suppl 1): S57-S64, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36128411
19.
WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants - Key considerations for global use.
Vaccine
; 40(26): 3506-3510, 2022 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35184927
20.
KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine.
NPJ Vaccines
; 7(1): 108, 2022 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36127367